Retamedix OÜ
Retamedix OÜ is a OÜ based in Kärdla linn, registry code 16407376, status: active. Main activity: Medical specialists activities. Its annual report for 2025 shows revenue of €91 573 and 1 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 91 573 €above 70% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 12.8 %above 58% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | 543 | 326 | — |
| Q2 2026 | — | 636 | 326 | — |
| Q1 2026 | — | 543 | 326 | — |
| Q4 2025 | — | 636 | 326 | — |
| Q3 2025 | — | 543 | 326 | — |
| Q2 2025 | — | 636 | 326 | — |
| Q1 2025 | — | 532 | 323 | — |
| Q4 2024 | — | 181 | 113 | — |
| Q3 2024 | — | 14 309 | 1 153 | — |
| Q4 2023 | — | 216 | 216 | — |
| Q3 2023 | — | 3 486 | 3 950 | — |
| Q2 2023 | — | 14 468 | 2 394 | 1 |
| Q1 2023 | — | — | — | 1 |
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 91 573 | 11 694 | 55 246 | 30 293 | 14 194 | 1 |
| 2024 | 129 748 | 43 382 | 51 515 | 65 061 | 45 882 | 1 |
| 2023 | 129 751 | 58 371 | 50 212 | 68 945 | 60 871 | 1 |
| 2022 | 86 819 | 49 423 | 32 574 | 58 966 | 51 923 | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 8 Apr 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 22 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 15 Mar 2024 | Company’s own | e-Äriregister |
| 2022 | 30 Dec 2021 – 31 Dec 2022 | 16 Feb 2023 | Company’s own | e-Äriregister |
Board
- Rene TambergBoard member · since 30 Dec 2021
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Rene TambergNatural person · 2 500 €
Beneficial owners
- Rene TambergDirect ownership · since 30 Dec 2021
Founders and other persons
- Rene TambergFounder · 2 500 € · 30 Dec 2021
Related companies
Activities (EMTAK)
- 86221Medical specialists activities Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50192855 / 5 10 Oct 2023 |
Amendment entry | In force 10 Oct 2023 |
||
| Ä 50192855 / M2 29 Sep 2023 |
Ruling to eliminate deficiencies | 14 Oct 2023 | Deficiencies eliminated 10 Oct 2023 |
|
| Ä 50192855 / 4 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50192855 / 3 16 Jan 2023 |
Amendment entry | In force 16 Jan 2023 |
||
| Ä 50192855 / M1 13 Jan 2023 |
Ruling to eliminate deficiencies | 25 Jan 2023 | Deficiencies eliminated 16 Jan 2023 |
|
| Ä 50192855 / 2 5 Sep 2022 |
Amendment entry | In force 5 Sep 2022 |
||
| Ä 50192855 30 Dec 2021 |
First entry | In force 30 Dec 2021 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data